Covered recipient · General Payments record
KINARD COOPER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$969.71
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $660.24 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $305.27 | 9 |
| Axsome Therapeutics, Inc. | $238.62 | 3 |
| Biogen, Inc. | $41.41 | 1 |
| Neurocrine BioSciences, Inc. | $22.77 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.38 | 1 |
| Teva Pharmaceuticals USA, Inc. | $19.19 | 1 |
| Vanda Pharmaceuticals Inc. | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.32 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950060 | CMS |
| ABBVIE INC. | $17.76 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950062 | CMS |
| ABBVIE INC. | $8.37 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950064 | CMS |
| ABBVIE INC. | $103.43 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950066 | CMS |
| ABBVIE INC. | $18.19 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950068 | CMS |
| ABBVIE INC. | $7.90 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950070 | CMS |
| ABBVIE INC. | $24.21 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950072 | CMS |
| ABBVIE INC. | $102.36 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950074 | CMS |
| ABBVIE INC. | $13.73 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106950076 | CMS |
| Axsome Therapeutics, Inc. | $96.66 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148379512 | CMS |
| Axsome Therapeutics, Inc. | $16.96 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148379514 | CMS |
| Axsome Therapeutics, Inc. | $125.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148379516 | CMS |
| Biogen, Inc. | $41.41 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104824162 | CMS |
| Neurocrine Biosciences, Inc. | $22.77 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150965131 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.38 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137728502 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.19 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151591365 | CMS |
| Vanda Pharmaceuticals Inc. | $13.60 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133937288 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.